- Report
- October 2024
- 197 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 196 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- July 2024
- 175 Pages
Global
From €4759EUR$5,000USD£3,994GBP
- Report
- November 2024
- 413 Pages
Global
From €5187EUR$5,450USD£4,354GBP
- Report
- February 2024
- 118 Pages
Global
From €4521EUR$4,750USD£3,795GBP
- Report
- March 2024
- 183 Pages
Global
From €2379EUR$2,500USD£1,997GBP
- Report
- January 2024
- 200 Pages
Global
From €3950EUR$4,150USD£3,315GBP
- Report
- October 2024
- 300 Pages
Global
From €3802EUR$3,995USD£3,192GBP
- Report
- January 2024
- 158 Pages
Global
From €2781EUR$2,923USD£2,335GBP
€3973EUR$4,175USD£3,335GBP
- Report
- October 2024
- 184 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 188 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 182 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 183 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 181 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 197 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 196 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 199 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 186 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 188 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
- Report
- October 2024
- 195 Pages
Global
From €3374EUR$3,545USD£2,832GBP
€3749EUR$3,939USD£3,147GBP
The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more